Marker Therapeutics Inc News - MRKR

Professional-Grade Tools, for Individual Investors.

Premium

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form PRE 14A - Other preliminary proxy statements

Form S-3 - Registration statement under Securities Act of 1933

Form D - Notice of Exempt Offering of Securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 8-K - Current report

Marker Therapeutics Announces $16.1 Million Private Placement

HOUSTON, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage...

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma

APOLLO study investigating MT-601 in patients with relapsed lymphoma: 78% of patients achieved objective...

Form 8-K - Current report

Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer

HOUSTON, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage...

Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium

HOUSTON, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage...

bar1080 2 hours ago

I'm a retired lawyer. I collect atrocious stocks.

👍️0

CorsairNavigator20 3 hours ago

Why are you here? Kick a stock when it is down. Are you with the Kennedie group as well? I would suggest you read a book, you will have a more productive time.

👍️0

bar1080 19 hours ago

Correction: "I don't own an itty bitty biomeds. Most are rubbish."

s/b I don't own ANY itty bitty biomeds. Most are rubbish.

👍️0

bar1080 1 day ago

I don't own an itty bitty biomeds. Most are rubbish.

👍️0

travayl 1 day ago

Maybe you should sell and move on?

👍️0

bar1080 1 day ago

What a piece of junk this stock is!

👍️0

ShadowHaven59 2 days ago

Thank you 👍 I apologize if this is not appropriate, I was just wondering what your opinion was on stem cell companies. I have a boatload of shares of the company LCTX. I was just wondering what your opinion is about that research. Thank you either way if you respond or don’t.

👍️0

Phantom Lord 2 days ago

Never trust analyst price targets on these small biotech companies. There are always ulterior motives.

👍️ 2

learningcurve2020 2 days ago

Hey Mod, this idiot exist to stalk me and contributes nothing to either board. Please have him removed. Thanks.

👙 1 👚 1

KIPK 2 days ago

ALL LC2020 Posts are totally IRRELEVANT!!!

👍️ 1 💯 2 🚀 1

learningcurve2020 2 days ago

It’s important to keep this guy’s name at the top just for accountability’s sake. Don’t let the link just disappear.

Dr. Huseynov:

https://www.moomoo.com/news/post/44817152/ladenburg-thalmann-maintains-marker-therapeutics-mrkrus-with-buy-rating-raises?level=2&data_ticket=1737645360288002

https://stockanalysis.com/analysts/aydin-huseynov/

https://www.benchmarkcompany.com/the-benchmark-company-expands-its-biotechnology-focus-with-the-addition-of-dr-aydin-huseynov-and-dr-okechukwu-linton/

👗 1 👙 1

learningcurve2020 3 days ago

Yep. Professor Vera and that Director guy who now owns Marker's manufacturing wing, are not giving shareholders anything to smile about.

👗 1 👙 1

learningcurve2020 3 days ago

Most likely answer is he was used to suck in retail then trap them.

👙 1 🚫 1

bar1080 4 days ago

Of course, you'll be tempted to average down... and down and down. Most of us know the drill. Seen it many times, including the BKs and suicides

BTW, I had another good day with my blue chips.

👍️0

microcapbiotech 4 days ago

Oh My, well it's just set it and forget it for the next 12 months. There will be no reason for a large price upswing without good new data news, and THAT is a Long Way Off.
If it gets below $1.50, I might be tempted to buy more, but not now.

👍️0

bar1080 4 days ago

Small biomeds are jokes and so are the "analysts." Please people, smarten up. Some here, lose over and over.

🤬 2

ShadowHaven59 4 days ago

How and why did this analyst give this company a double digit price target after speaking to the company? this is very frustrating.

👍️0

ah86 4 days ago

Damn! And to think we were at $5 not too long ago dreaming about the teens.

👍️0

ah86 4 days ago

new 52 week low! who is willing to buy more? come on now, we need yall to bid this up!!!

👍️0

microcapbiotech 4 days ago

No, I don't think they will cut back on grants. In the big picture, the amounts are miniscule to them and they are needed if they want smaller biotech's to have a shot at producing needed therapies.

👍️ 1

ShadowHaven59 5 days ago

I have read that this new administration, will speed up the process of getting drugs approved. Do you guys also think there is a possibility they will cut back on grants given to companies? Thank you.

👍️0

ShadowHaven59 1 week ago

I emailed them last month to complain like everyone else and they just emailed me back

👍️ 1

CorsairNavigator20 1 week ago

When did you get the letter from Marker. I didn't see one.

👍️0

CorsairNavigator20 1 week ago

Amen, I am 72 and I don't expect to see the data before I die as well. To me this type of behavior may imply that they have a subset which will respond well. The bad news is they will not say how big the patient population will be. I consider the AML relapse to be a dead indication, not sure if I go before the phase 3 is complete.
I am here for pancreatic, even in phase 1 data will tell if it's worth pursuing.

👍️ 3

microcapbiotech 1 week ago

Thank You. At least MRKR is "on track".
I am "on track" to die of old age before this company successfully completes a phase 3 trial with great data.

👍️ 4

ShadowHaven59 1 week ago

FWIW, I also received an email today from the company. Pretty much it’s the same that everyone else received. they are on track with their internal. enrollment schedule. they want to have a robust data set for the FDA. sorry to repeat the same information everybody else received. I just had to get this off my chest cause I am also frustrated. thank you.

👍️ 2

GoIrish1776 2 weeks ago

I didn't say anything about manly.

Congratulations. Last I checked, they don't determine the games winner on which team has the most hits. They determine it on who has more runs...total. :)

👍️ 2

ah86 2 weeks ago

To argue with bar1080 or other bears is to miss the point they are trying to make - this company disappoints.
I bought Phio Pharmaceuticals for $1.85 sometime back and sold at $5 yesterday. It topped out at $9.79
Do you care to know why it made that run? It reported data on 2 patients, yes! Two!
They now issued an offering. To be clear, they issued the offering AFTER they let the market had fun.
What was the timing of Marker's offering? Yes, at the same fcking time as the data release.
I hope y'all have an exit strategy.
Focus there instead of wasting your time bickering.

👍️ 1

jobynimble 2 weeks ago

Preliminary proxy statement, complete filing: https://www.sec.gov/Archives/edgar/data/1094038/000110465925003033/tm253006-1_pre14a.htm

NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
To Be Held On March 21, 2025

👍️ 1

bar1080 2 weeks ago

ThanksLC2020 98% of those slobbering gambling addicts would be better off in basic index funds like I and BRK own. But you know that.

👍️0

learningcurve2020 2 weeks ago

Why are you guys scolding Bar1080 for telling the truth?

👍️0

microcapbiotech 2 weeks ago

This is the only kind of forum where it can attempt to build up it's fragile ego that for some sad reason is apparently much needed in it's situation and in it's life.
Being an unwanted lunatic keyboard pansy warrior helps it increase it's obvious lack of self esteem and self worth.
It needs to consult a good psychologist or psychoanalyst to try fill the giant empty void by some productive means,

👍️0

CorsairNavigator20 2 weeks ago

What are you doing here? You have no interest in the stock, so you are wasting our and your time. Find somewhere else to be productive.

👍️ 2

learningcurve2020 2 weeks ago

Guess we can flush Dr. Huseynov's analysis down the toilet. Remember the name is all retail can do.

👍 1 💯 1

learningcurve2020 2 weeks ago

THE OFFERING
Common stock outstanding:
10,707,295 shares as of January 10, 2025
Common stock offered by the selling stockholders
10,062,500 shares consisting of (i) 1,783,805 shares of our common stock held by the selling stockholders, (ii) 3,247,445 shares of our common stock issuable upon exercise of outstanding Pre-Funded Warrants to purchase shares of our common stock held by the selling stockholders and (iii) 5,031,250 shares of common stock issuable upon the exercise of outstanding Private Placement Warrants held by the selling stockholders, which we collectively refer to as the Covered Shares
Common stock outstanding after the offering
18,985,990 shares(1)

👍️0

jobynimble 2 weeks ago

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

MARKER THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)

Complete filing: https://www.sec.gov/Archives/edgar/data/1094038/000110465925002600/tm252887-1_s3.htm

👍️ 1

microcapbiotech 2 weeks ago

bar1080, You just can't stop with your idiotic nonsense statements, can you? You said "Many of the world's great businesses never go public.", YES, but that has NOTHING to do with what I said.
I said "Every stock started out as a startup." Do you see the word "STOCK" you demented fool?
Seriously, what is wrong with you little buzzing gnat that you need to keep getting swatted?
Perhaps you, in all your wisdom should contact every hedge fund billionaire to tell them to just invest in blue chip index funds. After all, hedge fund billionaires need a good laugh too.
P.S. you keep saying things like "Adios", how about doing EVERYBODY a favor and actually mean it and follow through on your words.
As Yoda said: "Try not, do or do not, there is no try".

👍️0

microcapbiotech 2 weeks ago

How do I add a Clown emoji that I can use for bar1080?

👍️ 1

bar1080 2 weeks ago

Not true at all. "Every stock started out as a startup."

Many of the world's great businesses never go public. They often go public when they want to cash out of a bad business or continue a fat salary perpetually. The scams especially sell stock to the dumb money. Adios.

💯 1

microcapbiotech 2 weeks ago

What Mr. Index Fund Loon doesn't understand is that every stock started out as a startup. Nvidia, Apple, Microsoft, Tesla, etc., were all startups. Every stock in his index funds were startups.
If you invest in 20 biotech startups and 18 go bankrupt, you lost 1,800%, but if 2 make it big, like MANY HAVE, and go up 5,000%, then simple math is 5,000 X 2 = 10,000 - 1,800 = 8,200% profit.
Up 10,000% = 18,200% profit.
It's companies that I bought when they were small like NVDA, QCOM, VRTX, PCYC, SGEN, ALNY, and many others that make my loss in MRKR a nothing burger.
Mr. Loon is just a dullard coot who has nothing better to do than attempt to start arguments on a stock board page he has nothing to do with to try to fill a psychological need to make himself feel big and important. Somethings large and crucial must be missing in his life to have that need.

👍️ 2

bar1080 2 weeks ago

"If you're an adult, you take your lumps." So it's manly to take lumps. LOLOL. Not me. I'm a wimpy. multi-millionaire.

I have a profit in almost everything I own. Blue chips and index funds... and no shilled biomed rubbish.

👍️0

GoIrish1776 2 weeks ago

Shark tank is full of mom and pop ideas. It's not real venture capital in my opinion, investing in start-ups that have the opportunity to create massive change. That's why they put in small amounts at sub-$1m prices. It's like local bank lending or something. If you invest in a public entity like MRKR at a $20-30m mc, you better believe they can get a licensed drug that sells to some degree because you need to get to many, many multiples of the current mc.

As for start-ups being terrible bets, 9 of 10 are smoking holes in the ground. But that 1 in 10, that's the juice. That is what you have to look for. That is venture capital. If you don't have the taste for it, that's fine. However, Silicon Valley has created and captured trillions (with a T) in wealth. Investing in start-ups as a strategy is terrific. It's arguably the best asset class out there.

Now, MRKR looks like one of the 9 unfortunately. If you're an adult, you take your lumps, see what you believe, and decide what you want to do. That's where we are currently. I haven't given up hope, but I've grown more skeptical. I also haven't sat on the sidelines chirping. I can live with that.

And GO IRISH!

👍️ 2

bar1080 2 weeks ago

My personal losses are zero. Startups are terrible bets especially in biomed and that's assuming fraud isn't involved, and we know how much fraud lurks in penny stocks. It's much easier for a small but profitable business to grow into a bigger, more profitable business. That's what Buffett invests in. (such as his GEICO)

I think the TV program Shark tank does a major disservice in that regard. Clever-sounding ideas are a dime a dozen. Let the small company turn an audited few million in sales and profits... and I might be interested in making a sensible investment.

👍️ 2

learningcurve2020 2 weeks ago

The amount of public cash burned up in all these go nowhere biotechs is just staggering. Wonder what the total is in the last twenty years or so?

👍️0

bar1080 2 weeks ago

Gee, you're starting to catch on.

"Something tells me this is doing about nothing for the next year."

👍️0

microcapbiotech 2 weeks ago

Something tells me this is doing about nothing for the next year. I don't expect any earth shattering Lymphoma news for about a year, and I don't expect any meaningful Pancreatic news for about a year or two. I don't even know if they have enough money to last until some kind of good news, really can't count on more grant money coming. But just to stay consistent, I will click on the little green bull and keep waiting and hoping.

👍️0

CorsairNavigator20 2 weeks ago

At least they know what the product is supposed to be and how it works

👍️0

learningcurve2020 2 weeks ago

$30 million market cap now. Priced like a lab experiment with a scientist running the show.

👍️ 2

microcapbiotech 3 weeks ago

Heading towards the $2's again. Oh Joyous Day. Somebody give these people a big raise and bonus package.

👍️ 1

microcapbiotech 3 weeks ago

Sorry, I meant molasses going uphill in the winter.

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Marker Therapeutics Inc (MRKR)

Professional-Grade Tools, for Individual Investors.

MRKR News

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form PRE 14A - Other preliminary proxy statements

Form S-3 - Registration statement under Securities Act of 1933

Form D - Notice of Exempt Offering of Securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 8-K - Current report

Marker Therapeutics Announces $16.1 Million Private Placement

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma

Form 8-K - Current report

Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer

Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium

MRKR Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Marker Therapeutics Inc (MRKR) News

Marker Therapeutics Inc (MRKR)

Professional-Grade Tools, for Individual Investors.

MRKR News

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form PRE 14A - Other preliminary proxy statements

Form S-3 - Registration statement under Securities Act of 1933

Form D - Notice of Exempt Offering of Securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 8-K - Current report

Marker Therapeutics Announces $16.1 Million Private Placement

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma

Form 8-K - Current report

Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer

Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium

MRKR Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free